“Retrospective cost-utility and budget impact assessments of Hypericum perforatum in contrast with Fluoxetine treatment for depression in Karachi, Pakistan”, Braz. J. Pharm. Sci., vol. 55, p. e17210, Dec. 2019, doi: 10.1590/s2175-97902019000217210 .